Tags

Type your tag names separated by a space and hit enter

Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997.
MMWR Morb Mortal Wkly Rep. 1999 Oct 29; 48(42):961-7.MM

Abstract

Vaccination is an important public health intervention for reducing morbidity and mortality from influenza and pneumonia among persons with diabetes. A national health objective for 2000 is to increase influenza and pneumococcal vaccination rates to > or =60% among persons at high risk for complications from influenza and pneumonia, including persons with diabetes. Although the Advisory Committee on Immunization Practices (ACIP) recommends that all persons with diabetes be vaccinated, data from the 1993 Behavioral Risk Factor Surveillance System (BRFSS) showed that 40% of persons with diabetes reported receiving an influenza vaccination within the previous year, and 21% reported ever receiving a pneumococcal vaccination. To assess the vaccination rates among persons with diabetes in 52 reporting areas (i.e., 50 states, the District of Columbia, and Puerto Rico), CDC and the Council of State and Territorial Epidemiologists (CSTE) analyzed data from the 1997 BRFSS. This report summarizes the findings of this analysis, which indicate that most states did not reach the national health objectives for influenza and pneumococcal vaccination in their populations with diabetes.

Authors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10553810

Citation

Centers for Disease Control and Prevention (CDC). "Influenza and Pneumococcal Vaccination Rates Among Persons With Diabetes mellitus--United States, 1997." MMWR. Morbidity and Mortality Weekly Report, vol. 48, no. 42, 1999, pp. 961-7.
Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997. MMWR Morb Mortal Wkly Rep. 1999;48(42):961-7.
Centers for Disease Control and Prevention (CDC). (1999). Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997. MMWR. Morbidity and Mortality Weekly Report, 48(42), 961-7.
Centers for Disease Control and Prevention (CDC). Influenza and Pneumococcal Vaccination Rates Among Persons With Diabetes mellitus--United States, 1997. MMWR Morb Mortal Wkly Rep. 1999 Oct 29;48(42):961-7. PubMed PMID: 10553810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997. A1 - ,, PY - 1999/11/30/pubmed PY - 1999/11/30/medline PY - 1999/11/30/entrez SP - 961 EP - 7 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 48 IS - 42 N2 - Vaccination is an important public health intervention for reducing morbidity and mortality from influenza and pneumonia among persons with diabetes. A national health objective for 2000 is to increase influenza and pneumococcal vaccination rates to > or =60% among persons at high risk for complications from influenza and pneumonia, including persons with diabetes. Although the Advisory Committee on Immunization Practices (ACIP) recommends that all persons with diabetes be vaccinated, data from the 1993 Behavioral Risk Factor Surveillance System (BRFSS) showed that 40% of persons with diabetes reported receiving an influenza vaccination within the previous year, and 21% reported ever receiving a pneumococcal vaccination. To assess the vaccination rates among persons with diabetes in 52 reporting areas (i.e., 50 states, the District of Columbia, and Puerto Rico), CDC and the Council of State and Territorial Epidemiologists (CSTE) analyzed data from the 1997 BRFSS. This report summarizes the findings of this analysis, which indicate that most states did not reach the national health objectives for influenza and pneumococcal vaccination in their populations with diabetes. SN - 0149-2195 UR - https://www.unboundmedicine.com/medline/citation/10553810/Influenza_and_pneumococcal_vaccination_rates_among_persons_with_diabetes_mellitus__United_States_1997_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4842a3.htm DB - PRIME DP - Unbound Medicine ER -